Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells

Oncogene

Volumn 23, Issue 12, 2004, Pages 2161-2176

  Huang, Haojie ^a   Zegarra Moro, Ofelia L ^a   Benson, Douglas ^a   Tindall, Donald J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Androgen receptor; Bcl 2; Prostate cancer; RB; Transcription regulation

Indexed keywords

ANDROGEN; CYCLIN DEPENDENT KINASE INHIBITOR; MUTANT PROTEIN; PROTEIN BCL 2; PROTEIN P15; PROTEIN P27; RETINOBLASTOMA PROTEIN; RNA; SERINE; TRANSCRIPTION FACTOR E2F1; METRIBOLONE; SMALL INTERFERING RNA;

ARTICLE; BINDING SITE; CELL STRAIN; CONTROLLED STUDY; DOWN REGULATION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; UPREGULATION; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROSTATE TUMOR; REPORTER GENE; TRANSACTIVATION; TUMOR CELL LINE;

ANDROGENS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; MALE; METRIBOLONE; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA PROTEIN; RNA, SMALL INTERFERING; SERINE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 1842538716     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207326     Document Type: Article

References (53)

1. Agus DB, Cordon-Cardo C, Fox W, Drobnjak M, Koff A, Golde DW and Scher HI. (1999). J. Natl. Cancer Inst., 91, 1869-1876.
2. Bruckheimer EM, Spurgers K, Weigel NL, Logothetis C and McDonnell TJ. (2003). J. Urol., 169, 1553-1557.
3. Butler R, Mitchell SH, Tindall DJ and Young CY. (2000). Cell Growth Differ., 11, 49-61.
4. Cheema SK, Mishra SK, Rangnekar VM, Tari AM, Kumar R and Lopez-Berestein G. (2003). J. Biol. Chem., 278, 19995-20005.
5. Chi KN, Gleave ME, Klasa R, Murray N, Bryce C, Lopes de Menezes DE, D'Aloisio S and Tolcher AW. (2001). Clin. Cancer Res., 7, 3920-3927.
6. Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S and Buttyan R. (1993). Am. J. Pathol., 143, 390-400.
7. Cordon-Cardo C, Koff A, Drobnjak M, Capodieci P, Osman I, Millard SS, Gaudin PB, Fazzari M, Zhang ZF, Massague J and Scher HI. (1998). J. Natl. Cancer Inst., 90, 1284-1291.
8. Decary S, Decesse JT, Ogryzko V, Reed JC, Naguibneva I, Harel-Bellan A and Cremisi CE. (2002). Mol. Cell. Biol., 22, 7877-7888.
9. Denmeade SR, Lin XS and Isaacs JT. (1996). Prostate, 28, 251-265.
10. Dorai T, Goluboff ET, Olsson CA and Buttyan R. (1997a). Anticancer Res., 17, 3307-3312.
11. Dorai T, Olsson CA, Katz AE and Buttyan R. (1997b). Prostate, 32, 246-258.
12. Fernandez A, Udagawa T, Schwesinger C, Beecken W, Achilles-Gerte E, McDonnell T and D'Amato R. (2001). J. Natl. Cancer Inst., 93, 208-213.
13. Gleave M. (1999). Prostate Cancer Prostatic. Dis., 2, S15.
14. Gleave M, Tolcher A, Miyake H, Nelson C, Brown B, Beraldi E and Goldie J. (1999a). Clin. Cancer Res., 5, 2891-2898.
15. Gleave ME, Miayake H, Goldie J, Nelson C and Tolcher A. (1999b). Urology, 54, 36-46.
16. Gomez-Manzano C, Mitlianga P, Fueyo J, Lee HY, Hu M, Spurgers KB, Glass TL, Koul D, Liu TJ, McDonnell TJ and Yung WK. (2001). Cancer Res., 61, 6693-6697.
17. Graff JR, Konicek BW, McNulty AM, Wang Z, Houck K, Allen S, Paul JD, Hbaiu A, Goode RG, Sandusky GE, Vessella RL and Neubauer BL. (2000). J. Biol. Chem., 275, 24500-24505.
18. Green DR. (2000). Cell, 102, 1-4.
19. Grossmann ME, Huang H and Tindall DJ. (2001). J. Natl. Cancer Inst., 93, 1687-1697.
20. Haldar S, Basu A and Croce CM. (1997). Cancer Res., 57, 229-233.
21. Hiyama H, lavarone A and Reeves SA. (1998). Oncogene, 16, 1513-1523.
22. Huang H, Cheville JC, Pan Y, Roche PC, Schmidt LJ and Tindall DJ. (2001). J. Biol. Chem., 276, 38830-38836.
23. Huang H, Reed CP, Zhang JS, Shridhar V, Wang L and Smith DI. (1999). Cancer Res., 59, 2981-2988.
24. Huang H and Tindall DJ. (2002). Crit. Rev. Eukaryot. Gene Expr., 12, 193-207.
25. Huggins C and Hodge CV. (1941). Cancer Res., 1, 293-297.
26. Isaacs JT. (1984). Prostate, 5, 545-557.
27. Jiang Z and Zacksenhaus E. (2002). J. Cell. Biol., 156, 185-198.
28. Johnson DG, Ohtani K and Nevins JR. (1994). Genes Dev., 8, 1514-1525.
29. Kimura K, Markowski M, Bowen C and Gelmann EP. (2001). Cancer Res., 61, 5611-5618.
30. Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song K, Kitada S and Reed JC. (1996). Am. J. Pathol., 148, 1567-1576.
31. Kyprianou N, English HF and Isaacs JT. (1990). Cancer Res., 50, 3748-3753.
32. Lapointe J, Fournier A, Richard V and Labrie C. (1999). Endocrinology, 140, 416-421.
33. Li JM, Nichols MA, Chandrasekharan S, Xiong Y and Wang XF. (1995). J. Biol. Chem., 270, 26750-26753.
34. Liu SL, Rand A, Kelm Jr RJ and Getz MJ. (2000). Oncogene, 19, 3352-3362.
35. Lu L, Schulz H and Wolf DA. (2002). BMC Cell Biol., 3, 22.
36. Masiello D, Cheng S, Bubley GJ, Lu ML and Balk SP. (2002). J. Biol. Chem., 277, 26321-26326.
37. McDonnell TJ, Navone NM, Troncoso P, Pisters LL, Conti C, von Eschenbach AC, Brisbay S and Logothetis CJ. (1997). J. Urol., 157, 569-574.
38. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT, Tu SM and Campbell ML. (1992). Cancer Res., 52, 6940-6944.
39. Miyake H, Tolcher A and Gleave ME. (1999). Cancer Res., 59, 4030-4034.
40. Miyashita T, Harigai M, Hanada M and Reed JC. (1994). Cancer Res., 54, 3131-3135.
41. Murillo H, Huang H, Schmidt LJ, Smith DI and Tindall DJ. (2001). Endocrinology, 142, 4795-4805.
42. Neuman E, Flemington EK, Sellers WR and Kaelin Jr WG. (1994). Mol. Cell. Biol., 14, 6607-6615.
43. Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS and Buttyan R. (1995). Cancer Res., 55, 4438-4445.
44. Seto M, Jaeger U, Hockett RD, Graninger W, Bennett S, Goldman P and Korsmeyer SJ. (1988). EMBO J., 7, 123-131.
45. Swinnen JV, Ulrix W, Heyns W and Verhoeven G. (1997). Proc. Natl. Acad. Sci. USA, 94, 12975-12980.
46. Tsihlias J, Zhang W, Bhattacharya N, Flanagan M, Klotz L and Slingerland J. (2000). Oncogene, 19, 670-679.
47. Tsujimoto Y and Croce CM. (1986). Proc. Natl. Acad. Sci. USA, 83, 5214-5218.
48. Vigo E, Muller H, Prosperini E, Hateboer G, Cartwright P, Moroni MC and Helin K. (1999). Mol. Cell. Biol., 19, 6379-6395.
49. Weinmann AS, Bartley SM, Zhang T, Zhang MQ and Farnham PJ. (2001). Mol. Cell. Biol., 21, 6820-6832.
50. Westin P, Stattin P, Damber JE and Bergh A. (1995). Am. J. Pathol., 146, 1368-1375.
51. Wilson BE, Mochon E and Boxer LM. (1996). Mol. Cell. Biol., 16, 5546-5556.
52. Yang RM, Naitoh J, Murphy M, Wang HJ, Phillipson J, deKernion JB, Loda M and Reiter RE. (1998). J. Urol., 159, 941-945.
53. Zegarra-Moro OL, Schmidt LJ, Huang H and Tindall DJ. (2002). Cancer Res., 62, 1008-1013.